Markets › India › NSE › GLAND

Gland Pharma Ltd

NSE:GLANDHealthcareNSE:CNX500NSE:CNXMNC

₹3,019.80−0.78%At closeAt close · Mon 19 Oct · ≈ AED 116.51 · Market cap $5.26B · Next earnings Fri 6 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	53.5%	48.9%	48.7%	54.9%	56.2%	30.0%	—	—
Operating margin	41.0%	36.0%	31.9%	32.2%	30.9%	18.8%	18.8%	+0.0 pts
Net margin	28.8%	27.5%	21.5%	13.6%	12.4%	16.0%	16.0%	+0.0 pts
EBITDA margin	37.6%	34.3%	28.4%	22.9%	21.9%	29.9%	—	—
Return on equity	16.9%	16.9%	9.8%	8.9%	7.6%	9.9%	9.9%	+0.0 pts
Return on assets	15.3%	15.5%	8.9%	7.2%	6.2%	8.2%	8.2%	+0.0 pts
Return on capital employed	23.7%	21.8%	14.4%	19.7%	18.0%	11.1%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	0.1%	0.1%	0.1%	3.5%	2.8%	2.3%	—	—
Interest coverage	415.9×	302.2×	155.3×	69.6×	72.4×	36.2×	—	—
Current ratio	10.0×	10.1×	9.5×	4.0×	4.3×	4.7×	4.7×	+0.0%
Quick ratio	7.5×	7.9×	6.8×	2.8×	3.3×	3.6×	—	—
Cash ratio	1.0×	0.5×	2.6×	0.3×	1.6×	2.1×	2.1×	+0.0%
Asset turnover	0.5×	0.6×	0.4×	0.5×	0.5×	0.5×	—	—
Inventory turnover	1.2×	1.8×	0.9×	1.5×	1.5×	2.6×	—	—
Receivables turnover	4.7×	3.4×	3.5×	3.4×	3.7×	3.4×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	47.2%	28.9%	—	—